Improving Injectable Medicines Prescription in Outpatient Services: A Path Towards Rational Use of Medicines in Iran

Document Type: Policy Brief

Authors

1 Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

2 Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, and Pharmaceutical Economics and Decision-Making Research Center, Tehran University of Medical Sciences, Tehran, Iran

3 National Committee on Rational Medicine Use, Food and Drug Administration, Ministry of Health and Medical Education, Tehran, Iran

4 Department of Global Health and Public Policy, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Injection is one of the most common medical procedures in the health sector. Annually up to 16 billion injections are prescribed in low- and middle-income countries (LMICs), many of them are not necessary for the patients, increase the healthcare costs and may result in side effects. Currently over 40% of outpatient prescriptions in Iran contain at least one injectable medicine. To address the issue, a working group was established (August 2014 to April 2015) to provide a comprehensive policy brief to be used by national decision-makers. This report is the extract of methods that were followed and the main policy options for improving injectable medicines prescribing in outpatient services. Thirty-three potential policy options were developed focusing on different stakeholders. The panel reached consensus on seven policy options, noting effectiveness, cost, durability, and feasibility of each policy. The recommended policy options are targeted at patients and public (2 policies), insurers (2), physicians (1), pharmacies (1), and the Ministry of Health and Medical Education (MoHME) (1).

Keywords

Main Subjects


Additional File 1 (Download)

  1. Khan M, Ara N. Promoting rational prescribing among medical practitioners. Bangladesh Med J. 2014;40(2):6-7.
  2. World Health Organization (WHO). The Rational use of drugs: report of the conference of experts, Nairobi, 25-29 November 1985. Geneva: World Health Organization; 1987.
  3. World Health Organization (WHO). Promoting rational use of medicines: core components. Geneva: World Health Organization; 2002.
  4. Roberts MJ. Pharmaceutical reform: a guide to improving performance and equity. World Bank Publications; 2011.
  5. Rashidian A, Zaidi S, Jabbour S, Soleymani F, Jahanmehr N. Identification of priority policy research questions in the area of access to and use of medicines in EMRO Countries. http://www.who.int/alliance-hpsr/projects/alliancehpsr_iranlebanonpakistan_atmps.pdf. Published June 2011.
  6. Against all reason: misuse and overuse of injections. WHO website.  http://www.who.int/injection_safety/about/resources/Misuse/en/. Accessed January 14, 2015.
  7. Choi KH, Park SM, Lee JH, Kwon S. Factors affecting the prescribing patterns of antibiotics and injections. J Korean Med Sci. 2012;27(2):120-127. doi:10.3346/jkms.2012.27.2.120
  8. Sirnonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of blood-bome pathogens. Bull World Health Organ. 1999;77:789-800.
  9. Miller M, Pisani E. The cost of unsafe injections. Bull World Health Organ. 1999;77:808-811.
  10. 10.   Wyatt H, Mahadevan S. Unnecessary injections in developing countries: the risk and costs. Int J Risk Saf Med. 1993;4(2):167-176. doi:10.3233/JRS-1993-4206
  11. Sohn HS, Jang S, Han E, Lee EJ, Shin SA, Lee JY. Patient factors affecting frequent potential unnecessary injection use in outpatient care setting. Arch Pharm Res. 2015;38(7):1389-1396. doi:10.1007/s12272-014-0406-5.
  12. Technical activities: Injection safety. WHO website. http://www.who.int/patientsafety/activities/technical/injection_safety/en/. Accessed February 27, 2015. 
  13. Hutin YJ, Hauri AM, Armstrong GL. Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates. BMJ. 2003;327(7423):1075.
  14. Chowdhury AA, Roy T, Faroque A, et al. A comprehensive situation assessment of injection practices in primary health care hospitals in Bangladesh. BMC Public Health. 2011;11:779. doi:10.1186/1471-2458-11-779
  15. Kim DS, Hwang JH, Hwang JI. A multi-level analysis of injection requests and associated patient characteristics in the Korean acute-care outpatient setting. Kor J Clin Pharm. 2012;22(1):13-20.
  16. IPEN Study Group. Injection practices in India. WHO South-East Asia Journal of Public Health 2012;1(2):189-200.
  17. Vong S, Perz JF, Sok S, et al. Rapid assessment of injection practices in Cambodia, 2002. BMC Public Health. 2005;5:56.
  18. Garjani A, Salimnejad M, Shamsmohamadi M, et al. Effect of interactive group discussion among physicians to promote rational prescribing. East Mediterr Health J. 2009;15(2):408-415.
  19. Cheraghali AM, Nikfar S, Behmanesh Y, et al. Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran. East Mediterr Health J. 2004;10(3):406-415.
  20. The Ministry of Health and Medical Education (MOHME) of Iran. http://fdo.behdasht.gov.ir/uploads/114_1363_8_iran90.pdf
  21. Katzung BG, Masters SB, Trevor AJ. Basic & Clinical Pharmacology. New York: McGraw-Hill; 2004.
  22. Hogerzeil HV, Barnes KI, Henning R, et al. Teacher's guide to good prescribing. Geneva: WHO; 2001.
  23. Rashidian A. Study of adherence to guidelines and evidence (SAGE): theory-based analyses of beliefs, attitudes and prescribing outcomes in British primary care. UK: University of York; 2004.
  24. Wensing M, Grol R. Single and combined strategies for implementing changes in primary care: a literature review. Int J Qual Health Care. 1994;6(2):115-132.
  25. Ongolo-Zogo P, Bonono RC. Policy brief on improving access to artemisinin-based combination therapies for malaria in Cameroon. Int J Technol Assess Health Care. 2010;26(2):237-241. doi:10.1017/S0266462310000188
  26. Mclaws ML, Ghahramani S, Palenik CJ, Keshtkar V, Askarian M. Assessment of injection practice in primary health care facilities of Shiraz, Iran. Am J Infect Control. 2014;42(3):300-304. doi:10.1016/j.ajic.2013.09.006
  27. Raglow GJ, Luby SP, Nabi N. Therapeutic injections in Pakistan: from the patients' perspective. Trop Med Int Health. 2001;6(1):69-75.
  28. Shatsky M. Evidence for the use of intramuscular injections in outpatient practice. Am Fam Physician. 2009;79(4):297-300.
  29. Hwang JH, Kim DS, Lee SI, Hwang JI. Relationship between physician characteristics and their injection use in Korea. Int J Qual Health Care. 2007;19(5):309-316.
  30. le Grand A, Hogerzeil HV, Haaijer-Ruskamp FM. Intervention research in rational use of drugs: a review. Health Policy Plan. 1999;14(2):89-102.
  31. Hadiyono JE, Suryawati S, Danu SS, Santoso B. Interactional group discussion: results of a controlled trial using a behavioral intervention to reduce the use of injections in public health facilities. Soci Sci Med. 1996;42(8):1177-1183.
  32. Sarayani A, Rashidian A, Gholami K, Torkamandi H, Javadi M. Efficacy of continuing education in improving pharmacists' competencies for providing weight management service: three‐arm randomized controlled trial. J Contin Educ Health Prof. 2012;32(3):163-173. doi:10.1002/chp.21141
  33. Naeemeh Yousefi AR, Soleymani F, Kebriaeezade A. Relationship between the provision of injection services in ambulatory physician offices and prescribing injectable medicines. Iran J Pharm Res. 2016; Forthcoming.
  34. Chen M, Wang L, Chen W, Zhang L, Jiang H, Mao W. Does economic incentive matter for rational use of medicine? China’s experience from the essential medicines program. Pharmacoeconomics. 2014;32(3):245-255. doi:10.1007/s40273-013-0068-z